Balversa (Erdafitinib)
- Medicine Name: Balversa
- Generic Name: Erdafitinib
- Dosage Form & Strength: Tablets: 3 mg, 4 mg, & 5 mg
- Manufactured By: Janssen Pharmaceuticals, Inc.
Medical Uses
Balversa is a kinase inhibitor used for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma that has
- susceptible FGFR2/3 genetic alterations and
- progressed during or after at least one line of prior platinum-containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.
Recommended Dosage: The recommended starting dose is 8 mg (2 × 4 mg Balversa tablet) orally once daily, with a dose increase to 9 mg (3 × 3 mg tablets) once daily depending on serum phosphate levels and tolerability at 2 to 3 weeks.
Swallow tablets completely with or without food. In case vomiting occurs any time after taking tablets, the very next dose should be taken the very next day. Treatment should continue until the disease is progressive or unacceptable toxicity occurs.
If a dose is missed, it can be taken as promptly as possible on the same day. Resume the regular daily dose schedule the next day. Do not take extra tablets to make up for the missed dose.
Warning & Precautions
- Treatment with Balversa 4 mg can cause ocular disorders, including central serous retinopathy or retinal pigment epithelial detachment (CSR or RPED) resulting in visual field defect. Monthly ophthalmological examinations are required during the first four months of therapy and every three months afterwards, and urgently at any time for visual signs/symptoms.
- Increases in the levels of phosphate are a pharmacodynamic effect of Erdafitinib. Hyperphosphatemia was noted as a side effect in patients treated with Erdafitinib. Monitor them for hyperphosphatemia and follow the dosage modification guidelines when needed.
- As per findings, Balversa can cause fetal harm if given to a pregnant woman. Female patients of reproductive age should use apt contraception during treatment with balversa 3 mg and for one month after the final dose. Male patients with female partners of reproductive age should use apt contraception during therapy and for one month after the final dose.
- There is no finding on the existence of erdafitinib in human milk, or the effects of this medicine on the breastfed child, or on the production of milk. Due to the potential for severe side effects from erdafitinib in a breastfed child, lactating women should not breastfeed during therapy with erdafitinib and for 30 days after the final dose.
Documentation & Availability
What documents are required to import BALVERSA to India?
BALVERSA (erdafitinib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation are needed to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is BALVERSA available in India?
BALVERSA (erdafitinib tablets) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is facilitator providing input
- On availability of Balversa in India (Mumbai, Delhi, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
BALVERSA can be made available to patients, doctors and hospitals at Hyderabad, Mumbai, Kolkata, Ahmedabad, Delhi, Chennai, Bangalore, Srinagar, Jammu, Chandigarh, Ludhiana, Jaipur, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of BALVERSA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Toll-Free No: +91-7575883015 or write us at sshealthcare1012@gmail.com for Balversa price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the BALVERSA (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Balversa®?
Erdafitinib is Generic Name for the trade name drug Balversa®.
What is the Manufacturer Name of Balversa®?
Balversa® is manufactured by Janssen Pharmaceutical Companies.
Is Balversa® approved by the FDA?
Yes, Balversa® is approved by the US FDA. Date of first approval: April 12, 2019.
What is the dosage and form of Balversa® supplied?
This medicine is supplied for oral administration in three different dosage strength which are as:
- Balversa 3 mg Tablet
- Balversa 4 mg tablet
- Balversa 5 mg Tablet
What are the most common side effects with Balversa®?
The most common side effects with Balversa® include: mouth sores, feeling tired, diarrhea, dry mouth, change in liver function, low salt (sodium) levels, decreased appetite, change in sense of taste, anemia, dry skin, dry eyes, hair loss, constipation, stomach (abdominal) pain, nausea and muscle pain.
How much does Erdafitinib cost in India?
The erdafitinib cost in India is very reasonable and can vary. To procure this locally advanced/metastatic bladder cancer medicine authentically, you can call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Balversa®?
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F).
Is it safe to buy Balversa® online from India?
Yes, You can buy Balversa tablets online from India authentically from https://www.indianpharmanetwork.in/ if Balversa is not available or has not been approved in your home country.
What are the Highlights of prescribing information for Balversa®?
Click Here to download full Balversa prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
